UPDATE: Morgan Stanley Reiterates on Aetna Following Company Investor Day

By: Benzinga
In a report published Friday, Morgan Stanley analyst Andrew Schenker reiterated an Overweight rating on Aetna (NYSE: AET ), but removed the $83.00 price target. In the report, Morgan Stanley noted, “AET remains committed to growing operating earnings in 2014 and beyond. Despite expectations for flat operating EPS of 'at
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.